PercuVision Expands Board of Directors, As Company Focuses On Growth

Jan 05, 2016, 08:00 ET from PercuVision® LLC

COLUMBUS, Ohio, Jan. 5, 2016 /PRNewswire/ -- PercuVision® LLC, developer of patented micro-endoscope technologies to reduce pain and morbidity from blind urinary catheterizations, today announced that Thomas McDonald and Geoffrey Madden have been appointed to the company's board of directors.

The additions expand the company's board to six members. PercuVision currently is marketing its FDA-cleared DirectVision® System, a medical device that lets health practitioners view in real-time the inside of the urethra when placing urinary catheters.

"Having experienced executives like Tom and Geoff join our board provides PercuVision with greater resources, as we enter the next phase in our company's development and are now focused on expanding our customer base," said Errol Singh, M.D., F.A.C.S., a practicing urologist, inventor and CEO of PercuVision.

"We will continue to leverage the board's expertise and our company's leadership position, as we market our patented technology to the multi-billion dollar catheterization market, and as we further develop our technology for other applications, including nasogastric intubation, all with an objective of helping to improve patient care and outcomes," Dr. Singh added.

McDonald brings to PercuVision more than thirty years of experience in the finance and healthcare industries. He currently is founder and CEO of McDonald Partners, a Cleveland-based full-service brokerage and investment advisory firm. McDonald previously served as president and CEO of Wayne Hummer Investments, following a 12-year career at McDonald Investments. McDonald currently is chairman of the board of trustees of the MetroHealth Medical Center, an affiliate of the Case Western Reserve University School of Medicine, as well as a member of the board of the directors of Diasome Pharmaceuticals, Inc., a biotech company focused on the clinical and commercial development of breakthrough therapies for diabetes.

Madden is founding partner of Christman, Peters & Madden, a private investment banking firm headquartered in New York, which provides financial advisory and other services to middle-market companies in a diverse group of industries, including healthcare. Prior to founding Christman, Peters & Madden in 1989, Madden served as vice president of investment banking at Bateman Eichler, Hill Richards, a subsidiary of Kemper Insurance.  He previously was an associate in the corporate finance department of E. F. Hutton & Co.

Continuing PercuVision board members in addition to its chairman, Dr. Singh, are Mark Montoney, M.D., chief medical officer of Tenet Healthcare Corporation, Frank Murphy, chairman of University Housing Solutions, and Larry Jutte, president and COO of EG Industries.

PercuVision will also be participating at the 2016 J.P. Morgan Healthcare Conference in San Francisco January 11-14.

About PercuVision 
PercuVision® LLC's mission is to improve patient care and safety by applying micro fiber-optic bundle technology to common global medical procedures. The DirectVision® line of products use patented micro-endoscope technologies to bring vision to blind medical devices. More information on the company can be found by visiting www.PercuVision.com.

For more information, contact:

Roger Pondel/George Medici
PondelWilkinson Inc.
310-279-5980
rpondel@pondel.com 
gmedici@pondel.com

 

SOURCE PercuVision® LLC



RELATED LINKS

http://www.PercuVision.com